" Our approach combines in-house research with innovative technologies, all aimed at discovering and producing treatments for currently unmet medical conditions. ...Our central business strategy revolves around the development and supply of innovative medicines, responding to the increasing demand in the medical markets of Europe, North America, and Australasia."
what are the "unmet" medical conditions? Probably death would be one haha hasnt been cured yet. What else is there is that can be but isn't being treated by something. There are a lot of psychological conditions where need for treatment is unmet but that's not what MGC does. What do they mean by "unmet". Maybe they will have to first create these medical conditions for which there is no or not enough treatment yet. I'm really ignorant now about what MGC are doing that is innovative and what unmet medical condition needs they intend to meet, and where will they meet them.
Ann: Retraction of Statement, page-12
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.030(8.57%) |
Mkt cap ! $14.49M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 34.5¢ | 30.5¢ | $8.341K | 25.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2576 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 3292 | 2 |
View Market Depth
| Last trade - 15.51pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
33.0¢ |
Change
-0.030 ( 9.59 %) |
||||
| Open | High | Low | Volume | ||
| 31.5¢ | 33.0¢ | 31.0¢ | 4888 | ||
| Last updated 11.12am 05/06/2024 ? | |||||
| RGT (ASX) Chart |